Shanghai Cryowise Medical Technology Co., Ltd. was established in 2017, focusing on providing biopreservation tools for stem cell and regenerative medicine to maintain the health and function of biologic source material and finished products during manufacturing, distribution, and clinical administration.
1. Medical biopreservation products as auxiliary reagents for cell therapy.
2. Umbilical cord-derived MSC for liver disease, diabetes and other indications.
3. CDMO service platform for R&D and manufacturing of innovative stem cell products.